Article

Comparing apples and oranges

27 February 2023 – Here at Human Financial we’re always asking ourselves, “Which is the best asset mix to achieve our investment outcomes?”

As legendary investor Warren Buffet says, "Price is what you pay, value is what you get." But comparing the value of different assets can be a complicated business.

We use a variety of methodologies, but the simplest way to compare apples and oranges is to look at the income they generate. This approach isn’t perfect, as it ignores other characteristics such as volatility and liquidity risks; however, it does provide a reference point of relative valuation. It’s also the way most people compare different investments or assets in their everyday life: what yield can I get?

Equity Risk Premium

To compare equities and government bonds, for example, a commonly used metric is the equity risk premium (ERP), which provides a single measure that compares the relative attractiveness of equities to government bonds across time. The formula is:

applesOrangesImage02.png

Figure 1 shows the ERP for the S&P 500. ERP is regime dependent, i.e., it is not static, and its movements are driven by macro-economic factors. Having said that, it’s clear that US equities are currently at their most expensive levels since before the GFC. Despite the selloff in 2022, buying riskier equity assets currently yields you less than 2% more than the safe-haven asset of US treasuries.

This relative unattractiveness of equities is partly due to US 10y treasuries yielding close to 4%. Although this yield isn’t particularly appealing historically speaking, it’s at a level that investors could only have dreamt of during the last 15-odd years.

While our investment process doesn’t hinge on a single metric, the ERP does clearly highlight the need for caution within investment portfolios. Even after a poor performance in 2022 there may be more trouble for equities ahead.

applesOrangesImage01.png


This website has been prepared by Human Financial Management Limited (ABN 99 067 544 549, AFSL 227677) (HFML) without taking account of any individual’s objectives, financial situation or needs. Investors should consider the appropriateness of this information for their circumstances, read the product disclosure statement (PDS) , and obtain advice from a licensed financial adviser before making a financial decision.

The target market for each product is described in the relevant target market determination (TMD) .

Past performance is not a reliable indicator of future performance.

HFML believes that the information in this website and the sources on which it is based (which may be obtained from third parties) are correct as at the date of publication. This information may change from time to time. While every care has been taken in the preparation of this website, HFML does not guarantee its accuracy.

Read our Privacy Policy for information on how we handle your personal information.

© 2024 Human Financial